Julie S Torode: AACR and AORTIC Announce New BIG Cat Awards

AORTIC

Francesc Balaguer: A New Chapter in Lynch Syndrome Prevention

Francesc Balaguer

Precision and Speed Shouldn’t Be a Tradeoff - Varian

Precision and Speed

MASCC-ASCO-AAHPM-HPNA-NICSO Guideline on Opioid Conversion in Adults with Cancer

Opioid Conversion

Petros Grivas: Genetic Susceptibility and Environmental Risk Factors in Bladder Cancer

Petros Grivas: Genetic Susceptibility and Environmental Risk Factors in Bladder Cancer

Oncology News, Insights, Stories by OncoDaily

Enhertu+ pertuzumab
FDA Approvals

FDA Priority Review for Enhertu + Pertuzumab in first line HER2+ MBC

Zainab Shinkafi-Bagudu
Voices

Zainab Shinkafi-Bagudu: UNGA80 - A Critical Platform for Advancing Global Health Priorities

Paolo Tarantino and Jean-Charles Soria
Voices

Paolo Tarantino: Beyond the Guided Missile Paradigm of ADCs

Eric Small: Discussing ATOMIC and MATTERHORN Trials at Joint ASCO/SMeO Symposium

Embargoed News Going Out Tomorrow AM - National Pediatric Cancer WGS Program Results From Inocras + STREAM

Manel Esteller: The Story of a Record-Breaking Supercentenarian in an Aging World

Georgina Long: MORPHEUS Trial Testing Neoadjuvant Immunotherapy Combinations in Stage III Melanoma

Julie Gralow: High-Level Meeting on Non-Communicable Diseases and Mental Health

Debra Patt: The Power of Collaboration in Community Oncology

FDA Approves Imlunestrant (Inluriyo) for ESR1-Mutated Metastatic Breast Cancer

awards
awards
awards
awards
awards
awards
awards

Voices
Humaid Al-Shamsi

Humaid Al-Shamsi: First UAE and GCC Radiation Oncology Conference

Amol Akhade: Thirteen Key Late-Breaking Abstracts and Oral Presentations at ESMO25

The Max Foundation is Doubling Down to Reach 100,000 Cancer Patients Every Year by 2030

Wrap-Up of the AIEOP 2025 National Congress and Nursing Congress in Rome

Rachna Shroff: Expanding Clinical Trials Program at the University of Arizona Comprehensive Cancer Center

Kimberly Demirha: My Official Last Day with the ACCC

Harold Burstein: FDA Decision on Oral SERD Imlunestrant and Combo With Abemaciclib

Celebrities and Cancer

OncoCalendar

The ESO Refresher Course on Breast Cancer

European School of Oncology

21 Nov
ESO

CCI4EU 3rd Capacity Building Conference on Effective Patient Pathways

European School of Oncology

15 Oct
CCI4EU Conference

10th ESO SIOPE Masterclass in Paediatric Oncology

European School of Oncology

01 Oct
ESO SIOPE

50th International Congress "October Health Days"

European School of Oncology

23 Oct
Health Days

43rd Mexican National Congress of Oncology

SMeO – Mexican Society of Oncology

24 Sep
Mexican National Congress of Oncology

Immune-oncology
Perioperative Nivolumab ± Ipilimumab in Resectable Diffuse Pleural Mesothelioma

Perioperative Nivolumab ± Ipilimumab in Resectable Diffuse Pleural Mesothelioma

10 Must-Read Posts in Immuno-Oncology This Week

LIBRETTO-431 East Asia Subgroup Results of First-line Selpercatinib vs Chemotherapy + Pembrolizumab in RET Fusion–Positive NSCLC

Top Immunotherapy Trials in Head and Neck and Endocrine Cancers to Watch at ESMO 2025

10 Must-Read Posts in Immuno-Oncology This Week

BOT/BAL Advancements, BATTMAN Trial, FDA Approval Challenges and Key Highlights from Agenus Stakeholder Briefing

ROWAN Study of TheraSphere with Durvalumab and Tremelimumab in HCC Completed Enrollment

OncoGrants
ASTRO-PCF Young Investigator Award

ASTRO-PCF Young Investigator Award

ASTRO-AAPM Physics Residents/Postdoctoral Fellows Seed Grant

ASTRO-AAPM Physics Residents/Postdoctoral Fellows Seed Grant

ASTRO-LUNGevity Residents/Fellows in Radiation Oncology Seed Grant

ASTRO-LUNGevity Residents/Fellows in Radiation Oncology Seed Grant

ASTRO Residents/Fellows in Radiation Oncology Seed Grant

ASTRO Residents/Fellows in Radiation Oncology Seed Grant

ASTRO-BCRF Emerging Investigator Award

ASTRO-BCRF Emerging Investigator Award

ACS-ASTRO Felix Feng, MD Clinician Scientist Development Award

ACS-ASTRO Felix Feng, MD Clinician Scientist Development Award

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Colorectal Cancer

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

Craniopharyngioma: Symptoms, Diagnosis, Treatment, and 2025 Breakthroughs in Targeted Therapy and Precision Care

Malignant Schwannoma: Comprehensive Guide to Causes, Symptoms, Diagnosis, Treatment, Prognosis, and 2025 Advances in Schwannoma Care

Meningioma: Types, Symptoms, Diagnosis, Treatment, Malignancy Risk, and 2025 Breakthroughs

CancerWorld
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

Oncologists
Douglas Flora

Douglas Flora

Edgewood, USA
Aparna Parikh

Aparna Parikh

Boston, USA
Rachna Shroff

Rachna Shroff

Tucson, USA
Gregory Kalemkerian

Gregory Kalemkerian

Ann Arbor, USA
Hagop-Kantarjian

Hagop Kantarjian

Houston, USA
Sarkis Meterissian

Sarkis Meterissian

Montreal, Canada
Florian Lordick

Florian Lordick

Leipzig, Germany
LIdia Schapira

Lidia Schapira

Stanford, USA
Matti Aapro

Matti Aapro

Genolier, Switzerland
Rob Pieters

Rob Pieters

Utrecht, Netherlands
Giuseppe Curigliano

Giuseppe Curigliano

Milan, Italy
Yelena Janjigian

Yelena Janjigian

New York, USA

Oncology Drugs
Zongertinib (Hernexeos)

Zongertinib (Hernexeos) Updates 2025: Uses in Cancer, Side Effects, Dosage, Expectations, and More

Unreleased Decision Letters From 2024–2025 Now Available - FDA

Dordaviprone (Modeyso) 2025: What patients need to know?

The FDA Has Granted Accelerated Approval to Zongertinib - The Babak Lab

Dordaviprone (Modeyso) Updates 2025: Uses in cancer, Side effects, Dosage, Expectations and more

Zanidatamab (Ziihera): Patient Guide for 2025

Zanidatamab (Ziihera) Updates 2025: Uses in Cancer, Side Effects, Dosage, Expectations, and More

OncoDaily Magazine

awards
awards
awards
awards
awards
awards

New Paper Alert
bladder cancer

Muscle-Invasive Bladder Cancer: Therapy Advances and Access in Turkey

Vimseltinib

Vimseltinib (ROMVIMZA™) Gains European Commission (EC) Approval as First Targeted Therapy for TGCT

Durvalumab after Radiotherapy in Patients with Unresectable Stage III Non Small Cell Lung Cancer Ineligible for Chemotherapy

Durvalumab after Radiotherapy in Patients with Unresectable Stage III Non Small Cell Lung Cancer Ineligible for Chemotherapy

CABATEN Trial

New Paper Alert: CABATEN Trial Results- Cabozantinib and Atezolizumab Show Durable Responses in Rare Endocrine Cancers

A Systematic Review and Meta-Analysis of Cancer in Inborn Errors of Immunity

A Systematic Review and Meta-Analysis of Cancer in Inborn Errors of Immunity

Nationwide Real-World Evidence of Immunotherapy in Armenia

Nationwide Real-World Evidence of Immunotherapy in Armenia

OncoDaily Medical Journal

Precision Oncology

10.69690/ODMJ-019-0829-4588

Harnessing Real-World Evidence to Support Precision Oncology
Opinion

Pediatric Oncology

10.69690/ODMJ-001-0829-4568

Identifying the Factors Contributing to Treatment Abandonment in Childhood Cancers at a Tertiary Care Hospital in Pakistan
Original Research

Global Oncology

10.69690/ODMJ-001-0811-4701

The Role of National and Regional Cancer Registries in Shaping Cancer Care Policies
Original Research

Pediatric Oncology

10.69690/ODMJ-001-0809-4599

Survival Outcomes of Wilms' Tumor in Pediatric Patients Treated at KFMC: A Retrospective Study of 15 years from 2007-2022
Original Research

GI Oncology

10.69690/ODMJ-018-0425-4320

Colorectal Cancer in Latin America: Quick Comment
Commentaries

GI Oncology

10.69690/ODMJ-002-0701-4309

Current Perspective of Gastro-intestinal Cancer in Guatemala
Review/Meta-Analysis

Pediatric Oncology

10.69690/ODMJ-003-0520-4233

In the Crossfire: A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group
Editorial

Pediatric Oncology

10.69690/ODMJ-018-0425-4062

CD19+ CAR-T Therapy for Relapsed or Refractory B-ALL and Burkitt Lymphoma in Children and Young Adults in the Republic of Belarus
Abstracts